171 – 180 of 216
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Therapy with radiopharmaceuticals
(
- Contribution to journal › Article
-
Mark
Physical performance, toxicity, and quality of life as assessed by the physician and the patient
(
- Contribution to journal › Article
-
Mark
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin (R)) on a named patient basis in Sweden
(
- Contribution to journal › Article
-
Mark
Sensitizing and protective substances in radiation therapy and predictive assays
(
- Contribution to journal › Article
-
Mark
Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum
(
- Contribution to journal › Article
-
Mark
Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy
(
- Contribution to journal › Article
-
Mark
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
(
- Contribution to journal › Article
-
Mark
Chemoradiotherapy of esophageal cancer.
(
- Contribution to journal › Scientific review
-
Mark
Medical imaging for improved tumour characterization, delineation and treatment verification
(
- Contribution to journal › Article
-
Mark
Swedish Cancer Society radiation therapy research investigation.
(
- Contribution to journal › Article